Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR5 | P32302 | 17/20 | 0.50 |
| ▸ | PYGL | P06737 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | GHSR | Q92847 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1425219 | 0.89 | GHSR (0.53) | CXCR5GHSR | |
| SCHEMBL29707280 | 0.89 | GHSR (0.53) | CXCR5GHSR | |
| SCHEMBL5390112 | 0.85 | CXCR5 (0.46) | CXCR5GHSR | |
| SCHEMBL5404964 | 0.85 | GHSR (0.47) | CXCR5GHSR | |
| SCHEMBL5398474 | 0.83 | CXCR5 (0.47) | CXCR5GHSR | |
| SCHEMBL31232640 | 0.82 | GHSR (0.47) | CXCR5PYGLCYP2C9GHSR | |
| SCHEMBL26132071 | 0.82 | GHSR (0.47) | CXCR5PYGLCYP2C9GHSR | |
| SCHEMBL5388588 | 0.82 | ALDH1A1 (0.42) | CXCR5GHSR | |
| SCHEMBL30663978 | 0.82 | GHSR (0.41) | CXCR5GHSR | |
| SCHEMBL2405143 | 0.82 | NR1H2 (0.43) | CXCR5GHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7265220-B2 | Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative | LES LABORATORIES SERVIER (FR) | 2007-09-04 | — | — | US | disclosed |
| US-20050085517-A1 | Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative | LES LABORATOIRES SERVIER (FR) | 2005-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050085517-A1 | Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative | ARGLU1, PNISR, ATIC | CXCR5 721/4885PYGL 922/4885CYP2C9 56/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.